Research Material

This working group is focused to promote the identification/standardization of core outcomes set (COS) projects for clinical drug development in CNS therapeutic areas. Therefore, once identified good practices, next step is to promote its application by sponsors during the process of clinical trials design. Overall the idea is to promote good practices on the decision for COAs Selection in early clinical trials.
Generic placeholder image
COA Group - Background
Fundational Goals of The Group
Read More